RxDoctor Payments Data

Kimberly Lemoine, MD

Obstetrics & Gynecology · Saint Louis, MONPI 1811941248

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $24,868 of the $29,993 with a category attached, or 82.9%. Bayer accounts for 89.6% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2020 at $10,548 and has fallen 97.9% since, to $217 in 2025. Among obstetrics & gynecology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$29,993in general payments, 2019–2025

Across 279 payments — averaging $107.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$27K
  • AbbVie$931
  • Astellas Pharma US Inc$364
  • Sumitomo Pharma America, Inc.$222
  • Merz North America, Inc.$202
  • Amgen$197
  • plus $1K from 23 others

What the payments were for

  • Consulting fees$24,86883%
  • Speaking & faculty fees$1,7866%
  • Food & beverage$3,18811%
  • Education$1511%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,993 in reported general payments places this provider in the 95th percentile of 750 obstetrics & gynecology providers in Missouri.

See all obstetrics & gynecology providers in Missouri

Medicare billing

Part B allowed, 2024
$8,565
Medicare patients
93
Services billed
137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol53$3,456
ValacyclovirValacyclovir Hcl15$603
Raloxifene Hcl17$585
Clobetasol Propionate12$237
Fluconazole15$47

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →